Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score
Authors:
- 5 February 2024
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 33 (4) , 328-339
Abstract
Objective: Juvenile systemic lupus erythematosus (j-SLE) is a rare chronic auto-immune disease involving several organs. Neuropsychiatric (NP) SLE (NPSLE) is frequent in j-SLE and associated with increased morbidity/mortality. Although NPSLE classification criteria exist, attributing NP features to j-SLE remains a major challenge. The study objective is to thoroughly describe j-NPSLE patients and assist in their diagnosis. Methods: This is a 4-year retrospective monocentric study of j-SLE patients. NP events were attributed to j-SLE using standardised diagnostic criteria and multidisciplinary paediatric clinical expertise. Clinical features, brain magnetic resonance imaging (MRI)s and samples analysis including cerebrospinal fluid were assessed. A risk of j-NPSLE score was developed based on multivariable logistic regression analysis. Results: Of 39 patients included, 44% were identified as having j-NPSLE. J-NPSLE diagnosis was established at the onset of j-SLE in 59% of patients. In addition to frequent kidney involvement (76%) and chilblains (65%), all j-NPSLE patients displayed psychiatric features: cognitive symptoms (82%), hallucinations (76%), depressed mood (35%), acute confused state (18%) and catatonia (12%). Neurological involvement was often mild and nonspecific, with headache (53%) in about half of the patients. The main features reported on brain MRI were nonspecific T2/FLAIR white matter hyperintensities (65%), and cerebral atrophy (88%). Upon immunosuppressive treatment, clinical improvement of NP features was observed in all j-NPSLE patients. The score developed to attribute j-NPSLE probability, guide further investigations and appropriate treatments is based on hallucinations, memory, sleep and renal involvement (Sensitivity: 0.95 Specificity: 0.85). Cerebrospinal fluid (CSF) neopterin assessment increases the score sensitivity and specificity. Conclusion: Physicians should carefully and systematically assess the presence of NP features at diagnosis and early stages of j-SLE. For j-NPSLE patients with predominant psychiatric features, a multidisciplinary collaboration, including psychiatrists, is essential for the diagnosis, management and follow-up.Keywords
This publication has 43 references indexed in Scilit:
- Risk Factors for Neuropsychiatric Manifestations in Children With Systemic Lupus Erythematosus: Case-Control StudyPediatric Neurology, 2014
- Longterm Outcomes and Damage Accrual in Patients with Childhood Systemic Lupus Erythematosus with Psychosis and Severe Cognitive DysfunctionThe Journal of Rheumatology, 2013
- Prospective Study of Clinical Phenotypes in Neuropsychiatric Systemic Lupus Erythematosus; Multidisciplinary Approach to Diagnosis and TherapyThe Journal of Rheumatology, 2012
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsAnnals of the Rheumatic Diseases, 2010
- Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosusArthritis & Rheumatism, 2010
- Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2010
- Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosusLupus, 2007
- Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2005
- Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosusClinical Rheumatology, 2004
- Outcome in African-American children of neuropsychiatric lupus and lupus nephritisPediatric Nephrology, 2002